LD-2 disclosure · 2nd Quarter - Report
MYADERM
Client
- Name
- MYADERM
- Description
- Producer of pharmacist-formulated, transdermal Cannabidiol (CBD) pain creams and topical C
- Location
- Colorado · United States of America
Registrant
- Description
- law firm
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
3 issuesHealth Issues
FDA Policy regarding CBD transdermal pain products
LobbyistsTIMOTHY COSTA · mr MICHAEL P STRAZZELLA · ELIZABETH WESTBROOK
TargetedSENATE · HOUSE OF REPRESENTATIVES · Health & Human Services, Dept of (HHS) · Food & Drug Administration (FDA)
Pharmacy
FDA Policy regarding CBD transdermal pain products
LobbyistsTIMOTHY COSTA · mr MICHAEL P STRAZZELLA · ELIZABETH WESTBROOK
TargetedSENATE · HOUSE OF REPRESENTATIVES · Health & Human Services, Dept of (HHS) · Food & Drug Administration (FDA)
Medical/Disease Research/Clinical Labs
FDA Policy regarding CBD transdermal pain products
LobbyistsTIMOTHY COSTA · mr MICHAEL P STRAZZELLA · ELIZABETH WESTBROOK
TargetedSENATE · HOUSE OF REPRESENTATIVES · Health & Human Services, Dept of (HHS) · Food & Drug Administration (FDA)